AstraZeneca Plc said on March 14 a review of safety data of people vaccinated with the company’s Covid-19 vaccine has shown no evidence of an increased risk of blood clots.
https://www.pharmalive.com/wp-content/uploads/2021/03/AstraZeneca-finds-no-evidence-of-increased-blood-clot-risk-from-vaccine-Reuters-31421.jpeg240370Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-03-14 19:06:122021-03-14 22:22:07AstraZeneca finds no evidence of increased blood clot risk from vaccine